REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Hbm Pharma S.R.O. (Slovakia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Hbm Pharma S.R.O. Profile Updated: September 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

HBM Pharma s.r.o. manufactures and distributes pharmaceutical products. It supplies medicines and supplements to pharmacies. The company operates in the healthcare industry.

Headquarters
Sklabinska, 30
Martin; Zilinsky; Postal Code: 03680

Contact Details: Purchase the Hbm Pharma S.R.O. report to view the information.

Website: http://www.hbmpharma.eu

Basic Information
Total Employees:
Purchase the Hbm Pharma S.R.O. report to view the information.
Registered Capital:
Purchase the Hbm Pharma S.R.O. report to view the information.
Financial Auditors:
Purchase the Hbm Pharma S.R.O. report to view the information.
Incorporation Date:
March 02, 1992
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Hbm Pharma S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
0.34%▲
Total operating revenue
-0.05%▼
Operating Profit/Loss (EBIT)
-22.55%▼
EBITDA
-17.09%▼
Net Profit/Loss for the Period
-28.92%▼
Total Assets
6.81%▲
Total Equity
11.51%▲
Operating Profit Margin (ROS)
-3.29%▼
Net Profit Margin
-3.21%▼
Return on Equity (ROE)
-5.87%▼
Debt/Equity
-2.16%▼
Quick Ratio
0.76%▲

Similar companies

Saneca Pharmaceuticals A. S.
 
Hameln Rds S. R. O.
Unimed Pharma, Spol. S R.O.
 
Pharmagal - Bio, Spol. S R.O.
Imuna Pharm, A.S.
 
Biomin, A.S.
Panacea, S.R.O.
 
Galvex, Spol. S R.O.
Farmacia Martin A.S.
 
Pharmagal, Spol. S.R.O.

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo